Your trusted source for investing success

Tag: biotechnology

Ready to invest in Cannabis? Get your guide today.

Click below to get an INN Insider's Report on marijuana investing (value of $49) for FREE. Limited time offer. No credit card required.

Give me my free guide!
Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

Naturally Splendid Closes Second Tranche with Alumina Partners Ltd.

Naturally Splendid Closes Second Tranche with Alumina Partners Ltd.

Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or the “Company”) or (“NSE’) (FRANKFURT:50N) (TSX VENTURE:NSP) (OTC:NSPDF) is pleased to announce that on November 1, 2017, Naturally Splendid closed the second tranche under its previously announced non-binding draw-down equity facility for up to $6,000,000 with Alumina Partners (Ontario) Ltd., a subsidiary of

Valens GroWorks Added to CSE25 Index

Valens GroWorks Added to CSE25 Index

Valens GroWorks Corp. (CSE:VGW) (the “Company” or “Valens”), a biotechnology company specializing in the production, research, development and commercialization of novel, cannabinoid-based products and drug therapies, is pleased to announce its inclusion in the CSE25 Index.

PreveCeutical Receives Australian State Approval to Acquire and Use Cannabis as Part of Its Research and Development Program

PreveCeutical Receives Australian State Approval to Acquire and Use Cannabis as Part of Its Research and Development Program

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”) is pleased to announce that it has received approval (the “Approval”) from the Environmental Hazards Unit of the Queensland Government (the Australian state-level authority) to acquire, store and use high-quality cannabis oil and dried cannabis plant extracts.

Valens GroWorks Signs “MOU” With Okanagan Interventional Pain Clinic

Valens GroWorks Signs “MOU” With Okanagan Interventional Pain Clinic

Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), is pleased to announce the signing of a Memorandum of Understanding (“MOU”) with the Bill Nelems Pain and Research Centre, operating the Okanagan Interventional Pain Clinic, to form a strategic alliance for the purpose of conducting clinical research and development of

Valens Groworks arranges $500,000 private placement

Valens Groworks arranges $500,000 private placement

Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licenced, vertically integrated provider of cannabis products, is pleased to announce a follow up non-brokered private placement of up to 500,000 units (the “Units”) at a price of $1.00 per Unit for gross proceeds of up to $500,000 (the “Offering”).

3D Signatures Inc. Announces Brokered Private Placement

3D Signatures Inc. Announces Brokered Private Placement

3D Signatures Inc. (TSXV:DXD)(OTCQB:TDSGF)(FRANKFURT:3D0) (the “Company” or “3DS”) is pleased to announce that it has appointed a syndicate of agents led by Haywood Securities Inc. (“Haywood”), and including Industrial Alliance Securities Inc. (collectively with Haywood, the “Agents”), to sell, by way of a private placement on a best efforts basis,

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend